Viewing Study NCT00126893


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-02-20 @ 5:56 PM
Study NCT ID: NCT00126893
Status: TERMINATED
Last Update Posted: 2007-05-15
First Post: 2005-08-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia
Sponsor: Celgene Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module